Unbiased Analysis of Today's Healthcare Issues
Lakdawalla and Goldman. Tyler Cowen. AARP. National Pharmaceutical Council (from 2021) BIO. Adam Fein Here is a comparison of the CMS Final Rule (from 2021) vs. 2025 Trump Executive Order.
I’ll be at ISPOR. Health Care Subscriptions: Who Benefits and Who Gets Left Behind? NIH bans new funding from US scientists to scientists abroad Most favored nation. CDC: RSV vaccine works.
Three panels. One great city. Can’t wait for the conversations at ISPOR 2024 in Montréal. GCEA: Where do we go from here? (14 May, 5-6pm) Should we finally rethink the 3% discount rate? (15 May, 3:15-4:15pm) How can HEOR support providers in value-based care? (16 May, 10-11am) I’ll be diving into all three — including teaming…
Innovative Payment Models for Sickle-Cell Disease Gene Therapies. EHR records transfer: fax, CD, mail. ‘Why public health must always be led by economists’ Impact of federal cuts and inflation on food banks. End of an era?
It seems like the answer is now ‘yes’. EndPoints reports: Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or rejecting the company’s drug, elamipretide. It had been seeking regulatory clearance of elamipretide for a rare disease called Barth syndrome, which affects only about 150 people in the US and causes…
Only ⅔ of FDA-approved biosimilars have launched. Measles outbreak continues. UnitedHealth profits fall. Super-Earths. ‘Bone Collector’ caterpillars. NFL Draft comes to Green Bay.
At least according to CEOs from Novartis, Sanofi and AstraZeneca. Reuters reports: European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have triggered a wave of pharma investment announcements. AstraZeneca Chief Executive Officer Pascal Soriot said…
Tariffs on pharmaceuticals. First, President Trump has voiced his goal to impose tariffs on pharmaceutical products made overseas. The New York Times reports: Mr. Trump said in remarks to reporters on Monday that pharmaceutical tariffs would come in the “not too distant future.”“We don’t make our own drugs anymore,” Mr. Trump said. “The drug companies…
As reported by EndPoints: President Donald Trump on Tuesday signed an executive order offering support for a change to the IRA’s “pill penalty,” one of the industry’s long-standing policy priorities that could affect billions of dollars in drug costs under Medicare. The executive order on drug pricing contains a grab-bag of policy proposals, some of…
The Hill reports: The measles outbreak has now surpassed 700 reported cases in the U.S., raising the pressure on Health and Human Services Secretary Robert F. Kennedy Jr. to rein in the deadly virus.Overall, 712 cases have been reported with new cases being discovered in Kansas, Ohio and Indiana, according to the Centers for Disease Control and Prevention (CDC). The outbreak has…